Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases,including PTPN18 as a positive regulator of EPOR/JAK2 Signaling |
| |
| Institution: | 1. Neurosurgical Unit, Department of Biomedicine, Neurosciences, and Advanced Diagnostics, University of Palermo, Palermo, Italy;2. Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy;3. Department of Veterinary Sciences, University of Messina, Messina, Italy;4. Neurosurgical Unit, Department of Medical and Surgical Science, Magna Graecia University, Catanzaro, Italy;1. Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA 90095, USA;2. Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA;3. Jonnson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90095, USA;4. Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA 90095, USA;5. Department of Research and Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA 91343, USA;1. Division of Nephrology, Hypertension, and Transplantation, College of Medicine, University of Florida, Gainesville, FL, USA;2. Cloud Pharmaceuticals, Inc., 6 Davis Dr, Research Triangle Park, NC, 27709, USA;3. Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA;4. North Florida/South Georgia Veterans Health System, Gainesville, FL, USA;1. Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182-1030, USA;2. Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 North Torrey Pines Rd, La Jolla, CA 92037, USA |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
